|
ZNF271 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.48230008665007E-10 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
7.282900E-03 |
| Stage1-vs-Stage3 |
8.399500E-03 |
| Stage1-vs-Stage4 |
2.80429999999221E-07 |
| Stage2-vs-Stage3 |
2.565100E-04 |
| Stage2-vs-Stage4 |
2.75779999947545E-07 |
| Stage3-vs-Stage4 |
2.386100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
5.33739719088544E-12 |
| Normal-vs-Asian |
1.62458935193399E-12 |
| Caucasian-vs-AfricanAmerican |
7.590400E-01 |
| Caucasian-vs-Asian |
5.079600E-01 |
| AfricanAmerican-vs-Asian |
4.900800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.781600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
6.15160000050352E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.339800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.526800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.519200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.947400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.387000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.432000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.0508999998281E-07 |
| Classical-VS-Follicular |
1.586080E-04 |
| Classical-VS-Other |
7.062400E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
3.51300100120966E-11 |
| Tall-VS-Other |
1.020450E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.351200E-01 |
| Follicular-VS-Normal |
1.7027490528676E-12 |
| Other-VS-Normal |
8.16980000000189E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.025400E-04 |
|
|
